Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bayer to Pay Up to $800 Million for Algeta’s New Drug
Bayer to Pay Up to $800 Million for Algeta’s New Drug
Bayer to Pay Up to $800 Million for Algeta’s New Drug
Submitted by
admin
on September 3, 2009 - 8:45am
Source:
Bloomberg
News Tags:
Bayer
Algeta
Alpharadin
prostate cancer
Headline:
Bayer to Pay Up to $800 Million for Algeta’s New Drug
Do Not Allow Advertisers to Use My Personal information
